SlideShare a Scribd company logo
COPD
Chronic Obstructive
Pulmonary Disease
Mr. ANILKUMAR B R , Lecturer
Medical-Surgical nursing
Chronic Obstructive Pulmonary Disease or Chronic
Obstructive lung disease.
• Chronic obstructive pulmonary disease
(COPD)is a disease state characterized
by airflow limitation that is not fully
reversible.
• COPD may include diseases that cause
airflow obstruction (e.g., emphysema,
chronic bronchitis) or a combination of
these disorders.
• COPD includes chronic bronchitis and emphysema.
Asthma is not considered part of COP due its
reversibility.
1. Chronic bronchitis: is a chronic inflammation of the
lower respiratory tract characterized by excessive
mucous secretion, cough, & dyspnea associated
with recurrent infections of the lower respiratory
tract.
2. Emphysema: is a complex lung disease
characterized by damage to the gas- exchanging
surfaces of the lungs ( alveoli)
Chronic obstructive pulmonary disorders COPD
Risk Factors for COPD
1. Exposure to tobacco smoke accounts for an
estimated 80% to 90% of COPD cases. (
smoking)
2. Passive smoking
3. Occupational exposure
4. Ambient air pollution
5. Genetic abnormalities, including a deficiency
of alpha1-antitrypsin enzyme.
SMOKING
PATHOPHYSIOLOGY
Clinical Manifestations
• COPD is characterized by three primary symptoms:
1. Cough
2. Sputum production and
3. Dyspnea on exertion (DOE)
Dyspnea may be severe and often interferes
with the patient’s activities. Weight loss is
common because dyspnea interferes with
eating.
Assessment and Diagnostic Findings
1. History collection (The nurse should obtain a
thorough health history for a patient with
known or potential COPD).
Key Factors to Assess in the COPD
Patient’s Health History
1. Exposure to risk factors—types, intensity,
duration.
2. Past medical history—respirator
diseases/problems, including asthma, allergy,
sinusitis, nasal polyps, history of respiratory
Infections.
3. Family history of COPD or other chronic
respiratory diseases.
4. Pattern of symptom development.
5. History of exacerbations or previous
hospitalizations for respiratory problems.
6. Presence of comorbidities
7. Appropriateness of current medical
treatments
8. Impact of the disease on quality of life
9. Available social and family support for patient
10. Potential for reducing risk factors (e.g.,
smoking cessation).
2. Pulmonary function studies are used to help
confirm the diagnosis of COPD, determine
disease severity, and follow disease
progression.
3. Spirometry is used to evaluate airflow
obstruction.
4. Arterial blood gas (ABGs) measurements
may also be obtained to assess baseline
oxygenation and gas exchange.
5. Chest x-ray
6. alpha1antitrypsin deficiency screening may
be performed for patients under age 45 or for
those with a strong family history of COPD.
Complications
1. Respiratory insufficiency and Respiratory
failure are major life-threatening
complications of COPD.
2. Pneumonia & respiratory infection
3. Right-sided heart failure
4. Pulmonary hypertension
5. Pneumothorax
6. Skeletal muscle dysfunction
7. Depression and anxiety disorders
The objective of Management client with COPD
The main objective of COPD management are
Following:
1. Relieve symptoms
2. Prevent disease progression
3. Reduce mortality & improve exercise
tolerance
4. Prevent and treat complications
Medical Management
1. Risk reduction: Smoking cessation is the single
most effective intervention to prevent COPD or
slow its progression. ( smoking cessation is
major essential to reduce disease progression
and improve survival rate)
Nurses play a key role in promoting smoking
cessation and educating patients about ways to
do so. Patients diagnosed with COPD who
continue to smoke must be encouraged and
assisted to quit.
PHARMACOLOGIC THERAPY
• Bronchodilators: Bronchodilators relieve
bronchospasm and reduce airway obstruction
by allowing increased oxygen distribution
throughout the lungs and improving alveolar
ventilation.
• These medications, which are central in the
management of COPD are delivered through a
metered-dose inhaler (MDI) by nebulization,
or via the oral route in pill or liquid form.
A metered-dose inhaler(MDI) is a pressurized
device containing an aerosolized powder of
medication.
Metered-dose inhaler(MDI)
Corticosteroids
• Corticosteroids. Inhaled and systemic
corticosteroids (oral or intravenous) may also
be used in COPD but are used more frequently
in asthma.
• Although it has been shown that
corticosteroids do not slow the decline in lung
function, these medications may improve
symptoms.
• Other Medications including Patients should
receive a yearly influenza vaccine and the
pneumococcal vaccine every 5 to 7 years as
preventive measures.
MANAGEMENT OF EXACERBATION
• An exacerbation of COPD is difficult to
diagnose, but signs and symptoms may
include increased dyspnea, increased sputum
production and purulence, respiratory failure,
changes in mental status, or worsening blood
gas abnormalities.
• Primary causes for an acute exacerbation
include tracheobronchial infection and air
pollution.
OXYGEN THERAPY
OXYGEN THERAPY
• Oxygen therapy can be administered as long-
term continuous therapy, during exercise, or
to prevent acute dyspnea.
• Long-term oxygen therapy has been shown to
improve the patient’s quality of life and
survival.
Chronic obstructive pulmonary disorders COPD
PULMONARY REHABILITATION
• The primary goal of rehabilitation is to restore
patients to the highest level of independent
function possible and to improve their quality
of life.
• A successful rehabilitation program is
individualized for each patient, is
multidisciplinary, and attends to both the
physiologic and emotional needs of the
patient.
Components of pulmonary Rehabilitation
The treatment concept of COPD
RISK
REDUCTION
(SMOKING
CESSATION)
BRONCHODILAT
ORS
INHALED
CORTICO
STEROIDS
PULMONARY
REHABILIATION
SURGERY
Nursing Management client with
COPD
1. Assess the Clint status ask detail about smoking (pack
per year history), occupational exposure history,
positive family history of respiratory disease etc.)
2. Note amount, color and consistency of sputum.
3. The nurse should be inspect for use of accessory
muscles during respiration and use of abdominal
muscles during expirations.
4. The nurse plays a key role in identifying potential
candidates for pulmonary rehabilitation and in
facilitating and reinforcing the material learned in the
rehabilitation program.
Nursing Management client with COPD
• The nurse should teach to patient and family
as well as facilitating specific services for the
patient (e.g., respiratory therapy education,
physical therapy for exercise and breathing
retraining, occupational therapy, medications
using e.g. MDI, Nebulization for conserving
energy during activities of daily living, and
nutritional counseling)
PATIENT EDUCATION
• Patient education is a major component of
pulmonary rehabilitation and includes a broad
variety of topics.
• Depending on the length and setting of the
program, topics may include normal anatomy
and physiology of the lung, pathophysiology
and changes with COPD, medications and
home oxygen therapy, nutrition, respiratory
therapy treatments, symptom alleviation,
smoking.
Breathing Exercise
Inspiratory muscle training is defined as a course of therapy
consisting of a series of breathing exercises that aim to
strengthen the bodies' respiratory muscles making it easier for
people to breathe. Inspiratory muscle training is normally aimed
at people who suffer from asthma, bronchitis, emphysema and
COPD
• Self-Care Activities.As gas exchange, airway
clearance, & the breathing pattern improve,
the patient is encouraged to assume
increasing participation in self-care activities.
Oxygen Therapy. Oxygen supplied to the home comes
in compressed gas, liquid, or concentrator systems.
Portable oxygen systems allow the patient to exercise,
work, and travel.
Nutritional Therapy. Nutritional assessment and
counseling are important aspects in the rehabilitation
process for the patient with COPD.
Nursing diagnosis
1. Ineffective breathing pattern related to
chronic airflow limitation.
2. Ineffective airway clearance related to
bronchoconstriction, increased mucus
production, ineffective cough, possible
bronchopulmonary infection.
3. Risk for infection related to compromised
pulmonary function, retained secretions and
compromised defense mechanisms.
Nursing diagnosis
4. Imbalanced nutrition: less than body
requirements related to increased work of
breasting, presenting dyspnea & drug effects.
5. Deficient knowledge of self-care strategies to
be performed at home.

More Related Content

PPTX
COPD (Chronic obstructive Pulmonary Disease) PowerPoint Presentation -aslam
PPTX
CHRONIC OBSTRUCTIVE PULMONARY DISEASE
PPTX
Chronic obstructive pulmonary disease (COPD)- Preeti sharma
PDF
PPTX
PPTX
Pneumonia
PPTX
Diabetes Mellitus
PPTX
Hypertension
COPD (Chronic obstructive Pulmonary Disease) PowerPoint Presentation -aslam
CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Chronic obstructive pulmonary disease (COPD)- Preeti sharma
Pneumonia
Diabetes Mellitus
Hypertension

What's hot (20)

PPTX
Bronchial asthma
PPT
Lung abscess
PDF
Emphysema
PPTX
Pleural effusion
PPTX
Bronchiectasis
PPTX
Chronic renal failure (CRF)
PPTX
BRONCHIAL ASTHMA
PPTX
Angina Pectoris
PPTX
Benign prostate hyperplasia (BPH)
PDF
Pulmonary TB
PPTX
Epilepsy
PPT
Myocardial infarction
PPTX
bronchitis - CHRONIC BRONCHITIS
PPTX
Gastroenteritis
PPT
Bronchiectases
PPTX
Peptic ulcer
Bronchial asthma
Lung abscess
Emphysema
Pleural effusion
Bronchiectasis
Chronic renal failure (CRF)
BRONCHIAL ASTHMA
Angina Pectoris
Benign prostate hyperplasia (BPH)
Pulmonary TB
Epilepsy
Myocardial infarction
bronchitis - CHRONIC BRONCHITIS
Gastroenteritis
Bronchiectases
Peptic ulcer
Ad

Viewers also liked (13)

PPTX
BRONCHIAL ASTHMA
PPT
Copd imp د. جيهان
PPTX
Bronchial asthma
PPTX
Nursing management of the client with increased intracranial pressure
PPTX
Bronchiectasis
PPTX
Upper respiratory disorders and nursing mangement
PPTX
Chronic obstructive pulmonary disease (copd) power point
PPT
Copd update 2015
PPT
Bronchiectasis
PPT
Bronchiectasis
PPTX
Bronchial asthma and management RRT
PDF
Bronchial asthma
BRONCHIAL ASTHMA
Copd imp د. جيهان
Bronchial asthma
Nursing management of the client with increased intracranial pressure
Bronchiectasis
Upper respiratory disorders and nursing mangement
Chronic obstructive pulmonary disease (copd) power point
Copd update 2015
Bronchiectasis
Bronchiectasis
Bronchial asthma and management RRT
Bronchial asthma
Ad

Similar to Chronic obstructive pulmonary disorders COPD (20)

PPTX
TUTORIAL 7 COPD.pptx this slide is discuss about respiratory disease : pneumonia
PPTX
PPTX
cooooppppd.pptx acute exacerbation of asthma
PDF
Chronic obstructive pulmonary disorders COPD.pdf
PDF
Chronic obstructive pulmonary disorders COPD.pdf
PPTX
COPD vs Asthma.
PPT
COPD chronic obstructive pulmonary disease
PPTX
COPD treatment and nursing manageement .pptx
PPTX
Chronic Obstructive Pulmonary Disease
PPTX
Chronic obstructive pulmonary disease.pptx
PDF
Respi-COPD.pdf
PPTX
2.3) Chronic Obstructive Pulmonary Disease (COPD).pptx
PPTX
Chronic Obstructive Pulmonary Disease (COPD).pptx
PPTX
Chronic Obstructive Pulmonary Disease and ICU management.pptx
PPTX
Copd , septicshock
PPTX
Copd phenotypes
PPT
Copd lecture notes
PPTX
COPD(chronic obstructive pulmonary disease) ppt slideshare
PPTX
GOLD16 – MANAGEMENT AND TREATMENT OF COPD
TUTORIAL 7 COPD.pptx this slide is discuss about respiratory disease : pneumonia
cooooppppd.pptx acute exacerbation of asthma
Chronic obstructive pulmonary disorders COPD.pdf
Chronic obstructive pulmonary disorders COPD.pdf
COPD vs Asthma.
COPD chronic obstructive pulmonary disease
COPD treatment and nursing manageement .pptx
Chronic Obstructive Pulmonary Disease
Chronic obstructive pulmonary disease.pptx
Respi-COPD.pdf
2.3) Chronic Obstructive Pulmonary Disease (COPD).pptx
Chronic Obstructive Pulmonary Disease (COPD).pptx
Chronic Obstructive Pulmonary Disease and ICU management.pptx
Copd , septicshock
Copd phenotypes
Copd lecture notes
COPD(chronic obstructive pulmonary disease) ppt slideshare
GOLD16 – MANAGEMENT AND TREATMENT OF COPD

More from ANILKUMAR BR (20)

PPTX
Cranial nerve disorders
PPTX
Polices for intensive care units / critical care units
PPTX
RESUSCIATION EQUIPMENTS IN INTENSISIVE CARE UNITS
PPTX
Nursing management of critically ill patient in intensive care units
PPTX
Infection control protocols in intensive care units
PPTX
Deformities of ear
PPT
Pleural effusion
PPT
Deafness
PPTX
Modalities of treatment for cancer
PPTX
Prostate cancer
PPTX
Nursing management of patients with oncological conditions
PPTX
Glaucoma
PPTX
Conjunctivitis
PPTX
Nursing assessment and management of patients with hepatic disorders
PPTX
Ototoxicity
PPTX
Nursing assessment and Management clients with Pancreatic disorders
PPTX
PNEUMONIA
PPTX
The 10 rights of drug administration
PPTX
Thoracentesis
PPTX
Nephortic syndrome
Cranial nerve disorders
Polices for intensive care units / critical care units
RESUSCIATION EQUIPMENTS IN INTENSISIVE CARE UNITS
Nursing management of critically ill patient in intensive care units
Infection control protocols in intensive care units
Deformities of ear
Pleural effusion
Deafness
Modalities of treatment for cancer
Prostate cancer
Nursing management of patients with oncological conditions
Glaucoma
Conjunctivitis
Nursing assessment and management of patients with hepatic disorders
Ototoxicity
Nursing assessment and Management clients with Pancreatic disorders
PNEUMONIA
The 10 rights of drug administration
Thoracentesis
Nephortic syndrome

Recently uploaded (20)

PPTX
15.MENINGITIS AND ENCEPHALITIS-elias.pptx
PPTX
Slider: TOC sampling methods for cleaning validation
PPTX
CEREBROVASCULAR DISORDER.POWERPOINT PRESENTATIONx
PPTX
Respiratory drugs, drugs acting on the respi system
PDF
Writing and Teaching as Personal Documentation of Continuing Professional Dev...
PPTX
Self-nanoemulsifying Drug Delivery (SNEDDS) Approach To Improve Felodipine So...
PPTX
Nirsevimab in India - Single-Dose Monoclonal Antibody to Combat RSV .pptx
PPTX
1 General Principles of Radiotherapy.pptx
DOCX
RUHS II MBBS Pathology Paper-II with Answer Key | 1st August 2025 (New Scheme)
PPTX
NEET PG 2025 Pharmacology Recall | Real Exam Questions from 3rd August with D...
PPTX
Patholysiology of MAFLD/MASLD and Role of GLP 1 agonist in obesity and cardio...
PPT
ASRH Presentation for students and teachers 2770633.ppt
PDF
Solution of Psycho ED: Best Sexologist in Patna, Bihar India Dr. Sunil Dubey
PPT
Breast Cancer management for medicsl student.ppt
PPTX
fluids & electrolyte, Fluid and electrolytes
DOCX
RUHS II MBBS Microbiology Paper-II with Answer Key | 6th August 2025 (New Sch...
PDF
Neuro ED Bet Sexologist in Patna Bihar India Dr. Sunil Dubey
PPTX
neonatal infection(7392992y282939y5.pptx
PPTX
Pharmacology is the scientific study of how drugs and other chemical substanc...
PDF
Deadly Stampede at Yaounde’s Olembe Stadium Forensic.pdf
15.MENINGITIS AND ENCEPHALITIS-elias.pptx
Slider: TOC sampling methods for cleaning validation
CEREBROVASCULAR DISORDER.POWERPOINT PRESENTATIONx
Respiratory drugs, drugs acting on the respi system
Writing and Teaching as Personal Documentation of Continuing Professional Dev...
Self-nanoemulsifying Drug Delivery (SNEDDS) Approach To Improve Felodipine So...
Nirsevimab in India - Single-Dose Monoclonal Antibody to Combat RSV .pptx
1 General Principles of Radiotherapy.pptx
RUHS II MBBS Pathology Paper-II with Answer Key | 1st August 2025 (New Scheme)
NEET PG 2025 Pharmacology Recall | Real Exam Questions from 3rd August with D...
Patholysiology of MAFLD/MASLD and Role of GLP 1 agonist in obesity and cardio...
ASRH Presentation for students and teachers 2770633.ppt
Solution of Psycho ED: Best Sexologist in Patna, Bihar India Dr. Sunil Dubey
Breast Cancer management for medicsl student.ppt
fluids & electrolyte, Fluid and electrolytes
RUHS II MBBS Microbiology Paper-II with Answer Key | 6th August 2025 (New Sch...
Neuro ED Bet Sexologist in Patna Bihar India Dr. Sunil Dubey
neonatal infection(7392992y282939y5.pptx
Pharmacology is the scientific study of how drugs and other chemical substanc...
Deadly Stampede at Yaounde’s Olembe Stadium Forensic.pdf

Chronic obstructive pulmonary disorders COPD

  • 1. COPD Chronic Obstructive Pulmonary Disease Mr. ANILKUMAR B R , Lecturer Medical-Surgical nursing
  • 2. Chronic Obstructive Pulmonary Disease or Chronic Obstructive lung disease.
  • 3. • Chronic obstructive pulmonary disease (COPD)is a disease state characterized by airflow limitation that is not fully reversible. • COPD may include diseases that cause airflow obstruction (e.g., emphysema, chronic bronchitis) or a combination of these disorders.
  • 4. • COPD includes chronic bronchitis and emphysema. Asthma is not considered part of COP due its reversibility. 1. Chronic bronchitis: is a chronic inflammation of the lower respiratory tract characterized by excessive mucous secretion, cough, & dyspnea associated with recurrent infections of the lower respiratory tract. 2. Emphysema: is a complex lung disease characterized by damage to the gas- exchanging surfaces of the lungs ( alveoli)
  • 6. Risk Factors for COPD 1. Exposure to tobacco smoke accounts for an estimated 80% to 90% of COPD cases. ( smoking) 2. Passive smoking 3. Occupational exposure 4. Ambient air pollution 5. Genetic abnormalities, including a deficiency of alpha1-antitrypsin enzyme.
  • 9. Clinical Manifestations • COPD is characterized by three primary symptoms: 1. Cough 2. Sputum production and 3. Dyspnea on exertion (DOE) Dyspnea may be severe and often interferes with the patient’s activities. Weight loss is common because dyspnea interferes with eating.
  • 10. Assessment and Diagnostic Findings 1. History collection (The nurse should obtain a thorough health history for a patient with known or potential COPD).
  • 11. Key Factors to Assess in the COPD Patient’s Health History 1. Exposure to risk factors—types, intensity, duration. 2. Past medical history—respirator diseases/problems, including asthma, allergy, sinusitis, nasal polyps, history of respiratory Infections. 3. Family history of COPD or other chronic respiratory diseases. 4. Pattern of symptom development. 5. History of exacerbations or previous hospitalizations for respiratory problems.
  • 12. 6. Presence of comorbidities 7. Appropriateness of current medical treatments 8. Impact of the disease on quality of life 9. Available social and family support for patient 10. Potential for reducing risk factors (e.g., smoking cessation).
  • 13. 2. Pulmonary function studies are used to help confirm the diagnosis of COPD, determine disease severity, and follow disease progression. 3. Spirometry is used to evaluate airflow obstruction. 4. Arterial blood gas (ABGs) measurements may also be obtained to assess baseline oxygenation and gas exchange.
  • 14. 5. Chest x-ray 6. alpha1antitrypsin deficiency screening may be performed for patients under age 45 or for those with a strong family history of COPD.
  • 15. Complications 1. Respiratory insufficiency and Respiratory failure are major life-threatening complications of COPD. 2. Pneumonia & respiratory infection 3. Right-sided heart failure 4. Pulmonary hypertension 5. Pneumothorax 6. Skeletal muscle dysfunction 7. Depression and anxiety disorders
  • 16. The objective of Management client with COPD The main objective of COPD management are Following: 1. Relieve symptoms 2. Prevent disease progression 3. Reduce mortality & improve exercise tolerance 4. Prevent and treat complications
  • 17. Medical Management 1. Risk reduction: Smoking cessation is the single most effective intervention to prevent COPD or slow its progression. ( smoking cessation is major essential to reduce disease progression and improve survival rate) Nurses play a key role in promoting smoking cessation and educating patients about ways to do so. Patients diagnosed with COPD who continue to smoke must be encouraged and assisted to quit.
  • 18. PHARMACOLOGIC THERAPY • Bronchodilators: Bronchodilators relieve bronchospasm and reduce airway obstruction by allowing increased oxygen distribution throughout the lungs and improving alveolar ventilation. • These medications, which are central in the management of COPD are delivered through a metered-dose inhaler (MDI) by nebulization, or via the oral route in pill or liquid form.
  • 19. A metered-dose inhaler(MDI) is a pressurized device containing an aerosolized powder of medication.
  • 21. Corticosteroids • Corticosteroids. Inhaled and systemic corticosteroids (oral or intravenous) may also be used in COPD but are used more frequently in asthma. • Although it has been shown that corticosteroids do not slow the decline in lung function, these medications may improve symptoms.
  • 22. • Other Medications including Patients should receive a yearly influenza vaccine and the pneumococcal vaccine every 5 to 7 years as preventive measures.
  • 23. MANAGEMENT OF EXACERBATION • An exacerbation of COPD is difficult to diagnose, but signs and symptoms may include increased dyspnea, increased sputum production and purulence, respiratory failure, changes in mental status, or worsening blood gas abnormalities. • Primary causes for an acute exacerbation include tracheobronchial infection and air pollution.
  • 25. OXYGEN THERAPY • Oxygen therapy can be administered as long- term continuous therapy, during exercise, or to prevent acute dyspnea. • Long-term oxygen therapy has been shown to improve the patient’s quality of life and survival.
  • 27. PULMONARY REHABILITATION • The primary goal of rehabilitation is to restore patients to the highest level of independent function possible and to improve their quality of life. • A successful rehabilitation program is individualized for each patient, is multidisciplinary, and attends to both the physiologic and emotional needs of the patient.
  • 28. Components of pulmonary Rehabilitation
  • 29. The treatment concept of COPD RISK REDUCTION (SMOKING CESSATION) BRONCHODILAT ORS INHALED CORTICO STEROIDS PULMONARY REHABILIATION SURGERY
  • 30. Nursing Management client with COPD 1. Assess the Clint status ask detail about smoking (pack per year history), occupational exposure history, positive family history of respiratory disease etc.) 2. Note amount, color and consistency of sputum. 3. The nurse should be inspect for use of accessory muscles during respiration and use of abdominal muscles during expirations. 4. The nurse plays a key role in identifying potential candidates for pulmonary rehabilitation and in facilitating and reinforcing the material learned in the rehabilitation program.
  • 31. Nursing Management client with COPD • The nurse should teach to patient and family as well as facilitating specific services for the patient (e.g., respiratory therapy education, physical therapy for exercise and breathing retraining, occupational therapy, medications using e.g. MDI, Nebulization for conserving energy during activities of daily living, and nutritional counseling)
  • 32. PATIENT EDUCATION • Patient education is a major component of pulmonary rehabilitation and includes a broad variety of topics. • Depending on the length and setting of the program, topics may include normal anatomy and physiology of the lung, pathophysiology and changes with COPD, medications and home oxygen therapy, nutrition, respiratory therapy treatments, symptom alleviation, smoking.
  • 34. Inspiratory muscle training is defined as a course of therapy consisting of a series of breathing exercises that aim to strengthen the bodies' respiratory muscles making it easier for people to breathe. Inspiratory muscle training is normally aimed at people who suffer from asthma, bronchitis, emphysema and COPD
  • 35. • Self-Care Activities.As gas exchange, airway clearance, & the breathing pattern improve, the patient is encouraged to assume increasing participation in self-care activities.
  • 36. Oxygen Therapy. Oxygen supplied to the home comes in compressed gas, liquid, or concentrator systems. Portable oxygen systems allow the patient to exercise, work, and travel.
  • 37. Nutritional Therapy. Nutritional assessment and counseling are important aspects in the rehabilitation process for the patient with COPD.
  • 38. Nursing diagnosis 1. Ineffective breathing pattern related to chronic airflow limitation. 2. Ineffective airway clearance related to bronchoconstriction, increased mucus production, ineffective cough, possible bronchopulmonary infection. 3. Risk for infection related to compromised pulmonary function, retained secretions and compromised defense mechanisms.
  • 39. Nursing diagnosis 4. Imbalanced nutrition: less than body requirements related to increased work of breasting, presenting dyspnea & drug effects. 5. Deficient knowledge of self-care strategies to be performed at home.